Validations: Risk Ranking, Supplier Data & Precursors
Top Risk Ranking Mistakes—and How to Avoid Them Top Risk Ranking Mistakes—and How to Avoid Them The assessment and management of nitrosamine-related risks present significant challenges for pharmaceutical manufacturers, particularly given the stringent regulatory expectations from authorities such as the US FDA, EMA, and MHRA. Understanding frequent pitfalls in risk ranking methodologies is crucial for ensuring compliance and protecting public…
Non-Targeted Screening as a Trigger: When Ranking Says ‘Test’ Non-Targeted Screening as a Trigger: When Ranking Says ‘Test’ Introduction: Understanding Nitrosamine Risk Assessment The pharmaceutical industry is continually challenged by potential impurities that can impact drug safety and efficacy. Among such impurities, nitrosamines have garnered significant attention due to their classified status as probable human carcinogens. Nitrosamine risk assessment is…
Decision Trees for ‘Test vs Control’: Defensible Thresholds In the context of pharmaceutical manufacturing, the risk of nitrosamine contamination poses significant challenges and compliance demands. As regulatory bodies like the US FDA, EMA, and MHRA address these issues, professionals in the pharmaceutical sector must understand the mechanisms for effective nitrosamine risk assessment. This tutorial outlines a structured approach utilizing decision…
Regulatory Anchors: ICH M7 Hooks and US/EU Expectations The presence of nitrosamines in pharmaceutical products has raised significant concerns within the regulatory framework of the pharmaceutical industry. Regulatory bodies like the FDA and EMA have established guidelines to ensure the risk associated with these impurities is adequately assessed and controlled. This guide serves as a comprehensive tutorial for pharmaceutical professionals…
Materials of Construction: Elastomers, Tubing, and Valves Materials of Construction: Elastomers, Tubing, and Valves In the pharmaceutical industry, the materials of construction (MOC) for equipment such as elastomers, tubing, and valves play a critical role in ensuring product quality and safety. With increasing scrutiny from regulatory agencies like the US FDA, EMA, and MHRA regarding nitrosamine impurities, conducting a thorough…
Network Governance: Multi-Site Standardization of Risk Ranking Network Governance: Multi-Site Standardization of Risk Ranking Introduction to Nitrosamine Risk Assessment Nitrosamines are a class of compounds that have raised health concerns due to their potential carcinogenic effects. The detection and management of nitrosamines in pharmaceutical products is critical, particularly following the findings of nitrosamine contamination in several pharmaceutical drugs in recent…
Supplier Questionnaires for Nitrosamines: What to Ask and Why Supplier Questionnaires for Nitrosamines: What to Ask and Why As pharmaceutical manufacturers increasingly face scrutiny regarding nitrosamines, understanding how to implement effective nitrosamine risk assessment and management strategies becomes paramount. The risk of nitrosamines—specifically associated with cancer—requires robust protocols for evaluation and mitigation at all stages of pharmaceutical development and production….
Letters of Confirmation: Limits, Controls, and Change Notices Letters of Confirmation: Limits, Controls, and Change Notices Introduction to Nitrosamine Risk Assessment The pharmaceutical industry faces increasing scrutiny around the presence of nitrosamines in medicinal products, particularly with the introduction of strict guidelines from the FDA, EMA, and other regulatory authorities. In this article, we will explore the significance of Letters…
Precursor Libraries: Keeping Them Current Across Sites Precursor Libraries: Keeping Them Current Across Sites In today’s pharmaceutical environment, the management of precursor libraries has become essential for ensuring compliance with regulatory standards and maintaining product integrity. With the increasing scrutiny of nitrosamines related to drug precursors, the need for effective risk assessment strategies is more pressing than ever. This article…
Thermal/Process Stresses: Degradation Routes to Nitrosamines Thermal/Process Stresses: Degradation Routes to Nitrosamines In the pharmaceutical industry, the emergence of nitrosamines in drug products has sparked significant concern due to their potential carcinogenicity. This tutorial aims to elucidate the degradation pathways leading to nitrosamine formation, provide a comprehensive approach for nitrosamine risk assessment, and establish control strategies tailored to meet regulatory…